ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for GENETIX BIOTHERAPEUTICS, INC. · Biotechnology and pharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Oct 15, 2025

Lobbying activity 2

Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.